Stockreport

Can BioMarin (BMRN) Turn Margin Ambitions Into Strength Amid Rising Rare-Disease Competition? [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF outlined a target of reaching a 40% non-GAAP operating margin next year while sharpening its focus on genetically defined rare conditions. At the same time, an analyst [Read more]